|
Volumn 12, Issue , 2013, Pages
|
Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE;
3-NITROTYROSINE;
FASUDIL;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
PROSTACYCLIN;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PROTEIN KINASE INHIBITOR;
RHO KINASE;
TYROSINE;
VASODILATOR AGENT;
ANALOGS AND DERIVATIVES;
ANGIOCARDIOGRAPHY;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
COMPLICATION;
CORONARY ARTERY BLOOD FLOW;
CORONARY BLOOD VESSEL;
DIABETIC ANGIOPATHIES;
DRUG EFFECTS;
ENZYMOLOGY;
EXPERIMENTAL DIABETES MELLITUS;
FIBROSIS;
HEART MUSCLE;
MALE;
METABOLISM;
MICROCIRCULATION;
PATHOLOGY;
PATHOPHYSIOLOGY;
RADIOGRAPHY;
RAT;
SPRAGUE DAWLEY RAT;
VASOCONSTRICTION;
VASODILATATION;
1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE;
ANIMALS;
CORONARY ANGIOGRAPHY;
CORONARY CIRCULATION;
CORONARY VESSELS;
CYCLOOXYGENASE INHIBITORS;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETIC ANGIOPATHIES;
EPOPROSTENOL;
FIBROSIS;
MALE;
MICROCIRCULATION;
MYOCARDIUM;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
PROTEIN KINASE INHIBITORS;
RATS;
RATS, SPRAGUE-DAWLEY;
RHO-ASSOCIATED KINASES;
TYROSINE;
VASOCONSTRICTION;
VASODILATION;
VASODILATOR AGENTS;
|
EID: 84881124335
PISSN: None
EISSN: 14752840
Source Type: Journal
DOI: 10.1186/1475-2840-12-111 Document Type: Article |
Times cited : (36)
|
References (0)
|